Article Details
Retrieved on: 2025-04-17 13:42:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche has announced that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently ...
Article found on: www.selectscience.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here